Li Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Li Wang has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
Bing Lu
RNA Biomedical Institute, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China; Key Laboratory of Stem Cells and Tissue Engineering (Sun Yat-Sen University), Ministry of Education, Guangzhou, 510080, China
1 shared publicationBo Lin
Department of Breast and Thyroid Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
1 shared publicationChao Xiong
Department of Information, Affiliated Hospital of Guilin Medical University, Guilin, Guangxi 541001, China
1 shared publicationFuxi Li
RNA Biomedical Institute, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China; Key Laboratory of Stem Cells and Tissue Engineering (Sun Yat-Sen University), Ministry of Education, Guangzhou, 510080, China
1 shared publicationGuohao Lu
RNA Biomedical Institute, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, China; Key Laboratory of Stem Cells and Tissue Engineering (Sun Yat-Sen University), Ministry of Education, Guangzhou, 510080, China
1 shared publicationHuixian Wu
Guangxi Key Laboratory of Molecular Medicine in Liver Injury and Repair, the Affiliated Hospital of Guilin Medical University, Guilin, Guangxi 541001, China; Guangxi Health Commission Key Laboratory of Basic Research in Sphingolipid Metabolism Related Diseases, the Affiliated Hospital of Guilin Medical University, Guilin, Guangxi 541001, China
1 shared publication
Latest Publications
- Open Access
- 6 January 2026
- Published by Elsevier in Translational Oncology
- Vol. 64, 102646
MAZ-Mediated ubiquitin-conjugating enzyme E2C upregulation promotes breast cancer progression via the MAPK signaling pathway
- 6 January 2026
- Published by Elsevier in Translational Oncology
- Vol. 64, 102646
Open AccessMAZ-Mediated ubiquitin-conjugating enzyme E2C upregulation promotes breast cancer progression via the MAPK signaling pathway
- Open Access
- 1 March 2020
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 123, 109728
H3K27me3 loss plays a vital role in CEMIP mediated carcinogenesis and progression of breast cancer with poor prognosis
- 1 March 2020
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 123, 109728
Open AccessH3K27me3 loss plays a vital role in CEMIP mediated carcinogenesis and progression of breast cancer with poor prognosis